Patent details

EP1267945 Title: GENETICALLY MODIFIED CELLS EXPRESSING A TGF-BETA INHIBITOR, THE CELLS BEING LUNG CANCER CELLS.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1267945
WO Application Number:
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP01926498.5
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
30/03/2001
Grant date:
05/10/2011
EP Publication Date:
05/10/2011
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/10/2014
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
05/10/2011
EP B1 Publication Date:
05/10/2011
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
14/12/2011
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
29/03/2021
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
05/10/2011
 
 

 

Name:
NovaRx
Address:
6828 Nancy Ridge Drive Suite 100, San Diego, California, 92121, United States of America (US)

Domicile Holder

Name:
ir. H.A. Witmans c.s.
From:
05/10/2011
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Inventor

Name:
FAKHRAI, Habib
Address:
LA JOLLA, CA 92037, United States of America (US)

Priority

Priority Patent Number:
193497 P
Priority Date:
31/03/2000
Priority Country:
United States of America (US)

Classification

Main IPC Class:
A61K 48/00;
IPC or IDT classification:
A61K 35/42; A61P 35/00; C12N 5/10;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
2014/43
Publication date:
22/10/2014
Description:
Lapse or annulment

2

Bulletin Heading:
EP3
Journal edition number:
2012/01
Publication date:
04/01/2012
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
2011/41
Publication date:
12/10/2011
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201212
Publication date:
21/03/2012
Description:
Document reprinted after correction (B8, B9)

2

Issue number:
201140
Publication date:
05/10/2011
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
09/03/2013
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
700 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
14/12/2011 Incoming Correspondence Paper Other 1 PDF /8/9/4/6/2/0501926498/docs/ep01926498.5_0_incomingcorrespondencepaper20111214.pdf
14/12/2011 Claims Translated claims 3 PDF /8/9/4/6/2/0501926498/docs/ep01926498.5_3_claims20111214.pdf
25/10/2011 Incoming Correspondence Paper Correspondence address details 1 PDF /8/9/4/6/2/0501926498/docs/ep01926498.5_2_incomingcorrespondencepaper20111025.pdf
05/10/2011 Incoming Correspondence Paper Other 1 PDF /8/9/4/6/2/0501926498/docs/ep01926498.5_1_incomingcorrespondencepaper20111005.pdf